Sort by
Refine Your Search
-
Listed
-
Employer
- ;
- University of Nottingham
- UNIVERSITY OF SOUTHAMPTON
- Nature Careers
- UCL;
- UNIVERSITY OF MELBOURNE
- University of Birmingham
- University of Oxford
- University of London
- University of the West of England
- QUEENS UNIVERSITY BELFAST
- Queen's University Belfast;
- SINGAPORE INSTITUTE OF TECHNOLOGY (SIT)
- The University of Southampton
- UNIVERSITY OF SURREY
- University of Cambridge
- University of Exeter
- University of Glasgow
- University of Leeds
- University of Leeds;
- ; Technical University of Denmark
- ; University of Oxford
- Brunel University
- CRANFIELD UNIVERSITY
- CRUK Scotland Institute
- CZECH UNIVERSITY OF LIFE SCIENCES
- City University London
- Edinburgh Napier University;
- Imperial College London
- Nottingham Trent University
- Queen's University Belfast
- Rose Bruford College;
- The British Academy;
- University of Exeter;
- University of Hull
- University of Leicester
- University of Nottingham;
- University of Surrey
- University of Surrey;
- 29 more »
- « less
-
Field
-
to an exciting new effort to accelerate and miniaturise micro-elasticity imaging systems for in-vivo and clinical applications. You will be part of a dynamic, interdisciplinary team aiming
-
future generations. The Department comprises more than 25 research groups, working at every level of biological organization from genes to ecosystems. We are keen to increase diversity in our academic
-
is one of the top 80 universities in the world. We have a truly global community, with more than 39,000 students from 170 different countries and over 9,000 staff of 100 different nationalities
-
Job Description Position Details School of Chemistry, College of Engineering and Physical Sciences Location: University of Birmingham, Edgbaston, Birmingham UK Full time starting salary is normally
-
About us The UCL Cancer Institute is a £40 million investment in central London based at University College London (UCL), one of the world's top universities and a founding member of the Francis
-
emerging areas of interest, Birmingham is a dynamic place to work. We have ambitious plans to expand our research activity and are in an exciting period of growth: major investment from the University has
-
work with the Cambridge-GSK Translational Immunology Collaboration (https://www.med.cam.ac.uk/cg-tic ). This is a new interdisciplinary partnership between the University of Cambridge and GSK, bringing
-
essential for the development of targeted therapeutics. Using interdisciplinary approaches, we have identified and characterised atypical E3 ligases such as MYCBP2 and RNF213. MYCBP2 is a key regulator of
-
seeking a collaborative team player who thrives in a high-pressure, dynamic environment and is passionate about media production and education. If you're adaptable, technically skilled, and eager to inspire
-
molecular and structural mechanisms is essential for therapeutic development. Using E3 activity-based chemical probes, we have substantially expanded the known landscape of E3 ligase subtypes—effectively